NuGen Medical Devices Inc.

Recent News

• NuGen Medical Announces New Online B2C Subscription Business

  Toronto, Ontario--(Newsfile Corp. - March 29, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to announce its new B2C online subscription-based business to be offered at www.insujet.com will be available to consumers in the coming weeks ahead.By utilizing fulfillment centers across Europe and Canada, we ensure fast delivery for all purchases that can be made via smartphone or our web shop with just a few clicks. The customer's starter kit is then picked, packed,...

  2023-03-29 5:15 PM EDT
• NuGen Medical Reports Distribution Business Boasts Margins of 70%+

  Toronto, Ontario--(Newsfile Corp. - March 27, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to report that the Company's InsuJet™ needle-free injection device is actively sold in 11 countries through NuGen's distributor and wholesale network.InsuJet™ will soon be readily provided to end-customers throughout Europe through conventional channels, such as pharmacies for patients who have a prescription for the device. The reusable nature of InsuJet™ and its consumables allow competitive prices compared with conventional needles...

  2023-03-27 5:15 PM EDT
• NuGen Medical Announces the Return of Veronique Laberge as Chief Financial Officer and Corporate Secretary

  Toronto, Ontario--(Newsfile Corp. - March 10, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to announce that the Board of Directors has re-appointed Ms. Veronique Laberge as Chief Financial Officer and Corporate Secretary of the Company. "I am excited to return into the CFO role at NuGen and work with the new management team to help the company continue executing its strategic plan, accelerate growth and deliver value to shareholders," commented Veronique Laberge. "On...

  2023-03-10 5:15 PM EST
• NuGen Medical's Needle-Free Injection Device, InsuJet(TM) Delivers Increased Efficacy of Insulin for Diabetic Patient Care

  Toronto, Ontario--(Newsfile Corp. - March 3, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") reports its needle-free injection device, InsuJet™ provides over 40% faster insulin uptake[1] and significantly faster onset of action in diabetic patients compared to needle injections in multiple clinical studies performed in the Netherlands.Studies were performed at the Radboud University Medical Center in Nijmegen, Netherlands[2],[3] and were published in various influential medical journals including Diabetes Care. Many patients confirm they notice a faster...

  2023-03-03 5:15 PM EST
• NuGen Medical Announces the Appointment of Tony Di Benedetto as Executive Chairman and Director

  Toronto, Ontario--(Newsfile Corp. - February 28, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to announce that the Board of Directors has appointed Mr. Tony Di Benedetto as Executive Chairman and Director."I was approached by NuGen's new CEO, Richard Buzbuzian, who I had tremendous success with having built Drone Delivery Canada together from inception to then being named in 2021 the Best 50 top-preforming companies traded on the OTCQX Best Market. So, when Richard...

  2023-02-28 5:15 PM EST
• NuGen Medical Devices Inc. Announces the Appointment of Richard Buzbuzian as President, CEO and Director

  Toronto, Ontario--(Newsfile Corp. - February 22, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company") is pleased to announce that the Board of Directors has appointed Richard Buzbuzian as President, CEO and Director."InsuJet™, our needle-free injection device has tremendous sales opportunity globally and is approved for sale in 42 countries with active sales distribution agreements in 11. I look to complement our existing business with an expanded plan to monetize InsuJet sales with an ecommerce model, primarily B2C," commented...

  2023-02-22 4:30 PM EST
• NuGen Medical Devices Announces Closing of $2,500,000 Non-Brokered Private Placement of Units

  Toronto, Ontario--(Newsfile Corp. - February 14, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company") announces that it has closed its previously announced (see press release dated January 26, 2023) non-brokered private placement of units (the "Offering") through the issuance of 50,000,000 units (each a "Unit") at a price of $0.05 per Unit for aggregate gross proceeds of $2,500,000. Each Unit is comprised of one (1) common share in the capital of the Company ("Common Shares") and one (1)...

  2023-02-14 5:15 PM EST
• NuGen Medical Devices Announces New Unit Offering and Resignations and Appointment of An Officer and Director

  Toronto, Ontario--(Newsfile Corp. - January 26, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company") announces that it has closed its previously announced non-brokered private placement of units as described in its press release dated December 28, 2022 for total aggregate proceeds of $125,000. No additional tranches will be completed. The proceeds will be used by the Company for corporate and general working capital purposes.Further, the Company is pleased to announce a new non-brokered private placement financing (the...

  2023-01-26 9:00 AM EST
• NuGen Applies for Extension of Price Protection for Private Placement

  Toronto, Ontario--(Newsfile Corp. - August 10, 2022) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company") announces that in connection with the private placement (the "Offering") originally announced in the Company's press release of July 22, 2022, the Company has applied to the TSX Venture Exchange for an extension of a further 30 days price protection in order to complete further subscriptions. The Company intends the next tranche of the Offering to close in the next couple weeks.Further closing...

  2022-08-10 11:47 AM EDT
• NuGen Provides 2021 Year in Review and 2022 Corporate Update

  Toronto, Ontario--(Newsfile Corp. - January 12, 2022) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company") is pleased to provide an overview of its 2021 accomplishments and its corporate objectives for 2022. NuGen would first like to thank our shareholders for their continued support as the Company completed the Qualifying Transaction and achieved its public listing on the TSX Venture Exchange (the "Listing"). The Company is working towards its objectives of becoming the global leader of needle-free injection...

  2022-01-12 6:30 AM EST